4//SEC Filing
Ward Keith Wayne 4
Accession 0001209191-19-014057
CIK 0001358762other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:22 PM ET
Size
29.6 KB
Accession
0001209191-19-014057
Insider Transaction Report
Form 4
Ward Keith Wayne
See Remarks
Transactions
- Sale
Class A common stock
2019-02-25$91.00/sh−15,183$1,381,653→ 8,620 total - Sale
Class A common stock
2019-02-26$91.62/sh−8,367$766,585→ 8,620 total - Exercise/Conversion
Employee Stock Option (right to buy)
2019-02-25−15,183→ 92,967 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (15,183 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-02-26−16,817→ 76,150 totalExercise: $11.00Exp: 2026-05-25→ Class B common stock (16,817 underlying) - Exercise/Conversion
Class B common stock
2019-02-26$11.00/sh+16,817$184,987→ 16,817 total→ Class A common stock (16,817 underlying) - Exercise/Conversion
Class B common stock
2019-02-26$11.62/sh+8,367$97,225→ 25,184 total→ Class A common stock (8,367 underlying) - Conversion
Class A common stock
2019-02-25+15,183→ 23,803 total - Conversion
Class A common stock
2019-02-26+25,184→ 33,804 total - Sale
Class A common stock
2019-02-26$91.00/sh−16,817$1,530,347→ 16,987 total - Exercise/Conversion
Class B common stock
2019-02-25$11.00/sh+15,183$167,013→ 15,183 total→ Class A common stock (15,183 underlying) - Conversion
Class B common stock
2019-02-25−15,183→ 0 total→ Class A common stock (15,183 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2019-02-26−8,367→ 0 totalExercise: $11.62Exp: 2023-06-15→ Class B common stock (8,367 underlying) - Conversion
Class B common stock
2019-02-26−25,184→ 0 total→ Class A common stock (25,184 underlying)
Footnotes (4)
- [F1]The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2018.
- [F2]The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
- [F3]The options, representing a right to purchase a total of 108,150 shares, vest in sixteen equal quarterly installments beginning on August 25, 2016.
- [F4]The options, representing a right to purchase a total of 82,287 shares, vested in twenty equal quarterly installments beginning on September 15, 2013.
Documents
Issuer
REATA PHARMACEUTICALS INC
CIK 0001358762
Entity typeother
Related Parties
1- filerCIK 0001662394
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:22 PM ET
- Size
- 29.6 KB